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Secondly, the apparent lack of era effect on the frequency of CKD is interesting.
United States registry data has shown that the introduction of MELD has been accompanied by an increased likelihood of end-stage kidney disease, which has been attributed to greater pre-operative renal dysfunction (6) . Nevertheless, given that the adjusted hazard ratio for renal failure only rose by 15% after MELD implementation, one might not anticipate a demonstrable difference in this comparatively small study.
Without detailed information regarding additional recipient and donor factors it is difficult to draw any real conclusions regarding the evolving incidence of CKD.
Readers should not be falsely reassured by this data, especially in the face of an escalating use of higher risk grafts.
Finally, a major conclusion of the study by Allen et al was the limited reliability of creatinine-based GFR estimation in predicting mortality in these patients, and that preventative and expectant management based on early recognition of renal dysfunction may require actual measurement of GFR. We argue that measured GFR is time consuming, costly and not an applicable test for most transplant centres when repeated tests are necessary. Although a useful research tool, a single absolute measure of renal function in an individual patient is less relevant than delta estimated GFR for modifying clinical care.
